Hema Now: Episode 21: Global Perspectives on Myeloma
Claudio Cerchione discusses multiple myeloma, MRD, CAR-T therapy, and key takeaways from EHA and ASCO in this insightful hema now episode.
Related Articles
From Fractures to Futures
Professor Zoë Paskins explores the complexities and advancements in rheumatology and bone health in this episode – listen now
Lupus Vasculitis, a Rare Diagnosis and a Therapeutic Challenge: A Case Report
More than 50% of patients with systemic lupus erythematosus (SLE) develop lupus nephritis (LN) during the disease, which may manifest with…
EULAR 2025 Interview: Daniel Aletaha
RheumaFacts has been one of our major initiatives for some time. The idea is to gather information from all our member countries about…
Performance of Large Language Models in Real-World Interventional Cardiology Scenarios: The ILLUMINATE Randomised, Blinded Evaluation Study
The integration of AI in cardiology has advanced considerably with the emergence of large language models (LLM), which offer new…
Prenatal Tobacco Exposure Accelerates Brain Thinning in Adolescents, Study Reveals
Learn how prenatal tobacco alters teen brain development and behaviour, discover key findings and implications. Read more!
Self-Injection Device Offers Safe At-Home Acne Relief
Discover more about a newly developed self-injection device to inject low-dose triamcinolone directly into inflamed acne lesions. Learn more.
Healthy Lifestyle May Mitigate Telomere-Linked Brain Disease Risk
Healthy lifestyle choices could reduce risk of stroke, dementia, and late-life depression in individuals with biologically shorter telomeres.
Subscribe to our email newsletter
Subscribe to receive our free quarterly newsletters, journal publication alerts, and other relevant content.
Hema Now: Episode 19: Insights and Innovations in B Cell Disorders
Lydia Scarfò discusses types of leukaemia, current treatment approaches, recent advances, and future possibilities.
EULAR 2025: MRI Detects Early Spinal Changes in axSpA
EULAR 2025: MRI reveals early fat lesion progression in axSpA patients, distinguishing them from non-axSpA chronic back pain cases.